Regencell Bioscience Holdings Limited (RGC) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Regencell Bioscience Holdings Limited (RGC) closed at USD 8.11 on 2026-10-14, a change of -53.1 % over the past year, with a market capitalization of USD 4.72B.

Regencell Bioscience Holdings Limited recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Regencell Bioscience Holdings Limited key figures

Previous close

USD 8.11 (2026-10-14)

1-year change

-53.1 %

Market cap

USD 4.72B

Enterprise value

USD 4.71B

P/E ratio (trailing)

-317.33

P/E ratio (forward)

n/a

EPS (trailing)

-0.03

EPS (forward)

n/a

PEG ratio

n/a

Price to book

352.59

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.95

Employees

10

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Regencell Bioscience Holdings Limited and compare it with other stocks.